Mirae Asset Global Investments Co., Ltd. - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 174 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$118,847
-48.6%
27,511
-21.4%
0.00%
Q2 2023$231,077
-6.2%
34,985
-3.6%
0.00%
-100.0%
Q1 2023$246,314
+20.8%
36,276
+31.5%
0.00%0.0%
Q4 2022$203,904
-14.7%
27,592
+13.9%
0.00%0.0%
Q3 2022$239,000
+27.8%
24,218
+41.6%
0.00%
Q2 2022$187,00017,1070.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders